DE602006011650D1 - Behandlung von malignen neoplasien - Google Patents

Behandlung von malignen neoplasien

Info

Publication number
DE602006011650D1
DE602006011650D1 DE602006011650T DE602006011650T DE602006011650D1 DE 602006011650 D1 DE602006011650 D1 DE 602006011650D1 DE 602006011650 T DE602006011650 T DE 602006011650T DE 602006011650 T DE602006011650 T DE 602006011650T DE 602006011650 D1 DE602006011650 D1 DE 602006011650D1
Authority
DE
Germany
Prior art keywords
treatment
iodo
phenylalanine
neoplasia
malignes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006011650T
Other languages
German (de)
English (en)
Inventor
Samuel Samnick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE602006011650D1 publication Critical patent/DE602006011650D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Soft Magnetic Materials (AREA)
DE602006011650T 2005-11-25 2006-11-27 Behandlung von malignen neoplasien Active DE602006011650D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05025776 2005-11-25
PCT/EP2006/011367 WO2007060011A1 (en) 2005-11-25 2006-11-27 Therapy of malignant neoplasias

Publications (1)

Publication Number Publication Date
DE602006011650D1 true DE602006011650D1 (de) 2010-02-25

Family

ID=37744207

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006011650T Active DE602006011650D1 (de) 2005-11-25 2006-11-27 Behandlung von malignen neoplasien

Country Status (15)

Country Link
US (1) US8268888B2 (https=)
EP (1) EP1962822B1 (https=)
JP (1) JP5108781B2 (https=)
KR (1) KR20080074193A (https=)
AT (1) ATE454144T1 (https=)
AU (1) AU2006316781B2 (https=)
CA (1) CA2630848C (https=)
DE (1) DE602006011650D1 (https=)
DK (1) DK1962822T3 (https=)
ES (1) ES2341575T3 (https=)
IL (1) IL191690A (https=)
NZ (1) NZ568367A (https=)
PL (1) PL1962822T3 (https=)
PT (1) PT1962822E (https=)
WO (1) WO2007060011A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2948154C (en) 2014-05-07 2017-09-26 The University Of Akron Radioopaque, iodine functionalized phenylalanine-based poly(ester urea)s
WO2025202716A1 (en) * 2024-03-26 2025-10-02 Telix Pharmaceuticals (Innovations) Pty Ltd Combination therapy for treating glioblastomas

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5816999A (en) * 1997-07-24 1998-10-06 Bischoff; Jeffrey Flexible catheter for the delivery of ionizing radiation to the interior of a living body
AU1932900A (en) * 1998-12-04 2000-06-26 Medivas, Llc Methods for detection of vulnerable plaques using a detectable lipid-avid agent
WO2004050168A2 (en) * 2002-11-27 2004-06-17 Board Of Regents, The University Of Texas System Radiopharmaceuticals and radioactive microspheres for locoregional ablation of abnormal tissues

Also Published As

Publication number Publication date
KR20080074193A (ko) 2008-08-12
US8268888B2 (en) 2012-09-18
DK1962822T3 (da) 2010-05-17
EP1962822B1 (en) 2010-01-06
JP5108781B2 (ja) 2012-12-26
ES2341575T3 (es) 2010-06-22
PL1962822T3 (pl) 2010-07-30
AU2006316781A1 (en) 2007-05-31
WO2007060011A1 (en) 2007-05-31
AU2006316781B2 (en) 2012-06-14
JP2009517356A (ja) 2009-04-30
US20100003268A1 (en) 2010-01-07
ATE454144T1 (de) 2010-01-15
PT1962822E (pt) 2010-04-09
IL191690A0 (en) 2009-08-03
NZ568367A (en) 2010-11-26
IL191690A (en) 2011-10-31
EP1962822A1 (en) 2008-09-03
CA2630848A1 (en) 2007-05-31
CA2630848C (en) 2014-10-07

Similar Documents

Publication Publication Date Title
NO2017019I1 (no) Diarylhydantoinforbindelse, farmasøytisk sammensetning og anvendelse derav
TW200716646A (en) (S)-N-methylnaltrexone
EA201190217A1 (ru) Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение
EA200601776A1 (ru) Метадоновые композиции местного действия и способы их применения
MX2009006704A (es) Derivados de amina triciclicos como inhibidores de proteina de tirosina cinasa.
GEP20125565B (en) Lactam compounds and their pharmaceutical use
EA201001639A1 (ru) Композиции и способы их получения и применения
SE0301700D0 (sv) Novel compounds
EA201300242A1 (ru) Фармацевтические композиции, содержащие замещенные ациланилиды
WO2008148074A3 (en) Inhibitors of mtor and methods of treatment using same
TW200606162A (en) Pyrazolopyridine derivatives
CL2007000789A1 (es) Compuestos derivados de malonamida, inhibidores de la gamma-secretasa; proceso de preparacion; composicion farmaceutica; y su uso en el tratamiento de la enfermedad de alzheimer.
EA200801580A1 (ru) Новые производные пирониндола и способ их получения
EA200700096A1 (ru) Производные 2-карбамид-4-фенилтиазола, способ их получения и их применение в терапии
ATE448232T1 (de) Substituierte heterozyklen
MX2007011545A (es) Combinaciones para el tratamiento de cancer que comprenden el anticuerpo anti-egfr e inhibidores de vegfr.
CY1115961T1 (el) Ανυδρη μορφη κρυσταλλικης μηλεϊνικης ορβεπιταντης (orvepitant maleate)
CO5660287A2 (es) Derivados de tetrahidrocarbazol y su uso farmaceutico
SE0300098D0 (sv) Use of cyclin D1 inhibitors
ATE466841T1 (de) 1-phenethylpiperidinderivate und ihre verwendung als opioidrezeptor-liganden
EA201000141A1 (ru) Новые триазены для лечения рака
EA200501301A1 (ru) Ментоловые растворы лекарственных препаратов
SE0300457D0 (sv) Novel compounds
DK1596879T3 (da) Anvendelse af kahalalidforbindelser til fremstilling af et medikament til behandling af psoriasis
ATE454144T1 (de) Behandlung von malignen neoplasien

Legal Events

Date Code Title Description
8364 No opposition during term of opposition